The aim of this study was to examine whether the VHL-R167Q mutation, which is associated with a high risk of developing ccRCC (type 2B VHL disease), could impact the plasticity of renal carcinoma cells. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.